Post-approval studies (Phase 4)Study completedNCT06027567
What this trial is testing
The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure
Who this might be right for
Idiopathic Intracranial HypertensionIntracranial PressureObesity+3 more
Rigmor Højland Jensen 38